Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Anyone following that advice which first surfaced a few weeks back, plenty of time to buy, would have missed more than a triple. an almost 90% one day run means there is a great deal of momo which means (IMO) at least 60 cents by weekend, but more probably 80 before a correction just ahead of or immediately after news.

Second issue, “no reason for rise”:
1) anyone in this biopharma arena knows that IPIX is still greatly undervalued for a phase 3 enabled company. It should be minimally double today’s closing price.
2) O/S released Monday showed an O/S of less than 200mm shares. While that’s not the fully diluted count, it is at least 20mm less than most estimates. That alone is reason enough for a run above .25.
3) US trading rules are difficult to enforce against off-shore accounts, in particular those dealing with insider trading, and especially those dealing with leaks regarding EU regulatory outcomes.
4) keeping #3 in mind, it’s every bit possible that several things happened these last several days. IPIX received very favorable guidance and terms for an EU-based phase 3 trial that dovetails well with the FDA’s. The BP is finalizing its offer based on this feedback. There are now firm plans for a EU trial which is cheaper, less rigorous, and faster than a US trial.

One can wait if one wants, but by the time a correction sets in and news gives 100% assurance, one will be trying to accumulate above a buck fifty. That will surely make a nice double, though.